Northern Trust Corp Neuro Bo Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.72 - $1.54 $5,232 - $11,191	-7,267 Reduced 29.76%	17,155 $15,000
Q4 2021 Feb 08, 2022	SELL	$1.22 - $2.5 $268 - $550	-220 Reduced 0.89%	24,422 $30,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.52 $171 - $284	63 Added 0.26%	24,642 $92,000
Q2 2021 Aug 13, 2021	SELL	$2.74 - $4.63 $149,094 - $251,936	-54,414 Reduced 68.88%	24,579 $82,000
Q1 2021 May 12, 2021	SELL	$3.93 - $6.68 $7,337 - $12,471	-1,867 Reduced 2.31%	78,993 $348,000
Q4 2020 Feb 11, 2021	SELL	$5.02 - $6.59 $23,011 - $30,208	-4,584 Reduced 5.36%	80,860 $425,000
Q3 2020 Nov 16, 2020	BUY	$5.41 - $8.67 $39,411 - $63,160	7,285 Added 9.32%	85,444 $479,000
Q2 2020 Aug 14, 2020	BUY	$8.05 - $29.44 $629,179 - $2.3 Million	78,159 New	78,159 $629,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.